AssetMark’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
AssetMark's ROIV Position: Q3 2026 in Review
AssetMark increased its Roivant Sciences (ROIV) stake by 43% in Q3 2026, buying an estimated $5.87K and bringing the position to 541 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.
AssetMark first reported a position in ROIV in Q2 2024 and has held it in 10 quarters since. 405 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- AssetMark held 541 shares of Roivant Sciences worth $19.8K as of Q3 2026.
- AssetMark bought 162 Roivant Sciences shares in Q3 2026, an estimated $5.87K.
- Roivant Sciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2254 holding.
- AssetMark first reported a position in Roivant Sciences in Q2 2024 and has held it in 10 quarters since.
- 405 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.